Retrospective Cohort Study
Copyright ©The Author(s) 2024.
World J Clin Cases. Jun 16, 2024; 12(17): 2976-2982
Published online Jun 16, 2024. doi: 10.12998/wjcc.v12.i17.2976
Table 1 Baseline characteristics of the patients with diabetic foot ulcers
Variable
Experimental group (n = 32)
Control group (n = 30)
P value
Age (yr)58.6 ± 9.460.1 ± 8.70.46
Sex (male/female)18/1416/140.77
BMI (kg/m2)24.3 ± 3.223.9 ± 2.90.64
Duration of diabetes (yr)12.4 ± 6.313.2 ± 5.80.57
Type of diabetes (type 1/type 2)4/285/250.72
HbA1c (%)8.7 ± 1.68.9 ± 1.40.51
Wound location (foot/lower leg)26/624/60.91
Wound size (cm2)12.5 ± 8.713.2 ± 9.40.74
Wound depth (cm)2.1 ± 1.22.3 ± 1.30.56
Wagner grade (2/3/4/5)8/12/8/49/10/7/40.88
Table 2 Clinical outcomes of the patients with diabetic foot ulcers under the comprehensive and standard treatment protocols
Variable
Experimental group (n = 32)
Control group (n = 30)
P value
Time to reduce white blood cell count (d)3.2 ± 1.45.6 ± 2.1< 0.001
Number of dressing changes12.3 ± 4.518.7 ± 6.3< 0.001
Wound healing rate (%)87.553.30.003
Wound healing time (d)28.4 ± 9.742.6 ± 12.4< 0.001
Amputation rate (%)6.326.70.02